Blood tests can detect THC, the main psychoactive compound in cannabis, along with several of its breakdown products. Unlike urine tests, which pick up a metabolite that can linger for weeks, blood tests are better at capturing recent use because THC itself clears from the bloodstream relatively quickly in most people. But “quickly” is relative, and detection times vary enormously depending on how often you use cannabis, your body composition, and what the lab is actually measuring. The distinction between occasional and frequent users matters far more than most people realize.
What a Blood Test Actually Measures
When a lab runs a cannabis blood test, it can look for several different molecules. The most commonly targeted are THC itself (delta-9-tetrahydrocannabinol), 11-OH-THC (the active metabolite your liver produces as it processes THC), and THC-COOH (an inactive metabolite that sticks around much longer). Each tells a different story. THC in your blood rises fast after smoking and drops quickly, making it a rough marker of recent intake. 11-OH-THC peaks slightly later and is particularly relevant for edibles, since your liver converts more THC into this active form when cannabis is swallowed rather than inhaled. THC-COOH, by contrast, accumulates over time and can remain detectable in regular users long after any high has worn off.
One wrinkle that trips people up is the difference between whole blood and plasma. THC binds heavily to proteins in plasma and does not distribute well into red blood cells. As a result, concentrations in whole blood run roughly 40% of what you would see in plasma for the same sample. Median whole-blood-to-plasma ratios sit around 0.39 for THC and 0.37 for THC-COOH.1PubMed Central. Intra- and intersubject whole blood/plasma cannabinoid ratios determined by 2-dimensional, electron impact GC-MS with cryofocusing This means a result reported in plasma looks about two and a half times higher than the same person’s whole-blood result. If you are comparing your number to a legal limit or a workplace cutoff, you need to know which matrix was tested, because the numbers are not interchangeable. A multiplying factor of roughly 1.6 can convert whole-blood concentrations to estimated plasma levels, though individual variation exists.2PubMed. Delta(9)-THC, 11-OH-Delta(9)-THC and Delta(9)-THCCOOH plasma or serum to whole blood concentrations distribution ratios in blood samples taken from living and dead people
Detection Windows for Occasional Users
If you smoke cannabis once and are not a regular user, THC in your blood typically peaks within minutes and falls below detectable levels within a few hours. After a single smoked dose under controlled conditions, median peak whole-blood THC reached about 50 micrograms per liter at around 15 minutes, then dropped sharply.3PubMed Central. Identification of Recent Cannabis Use: Whole-Blood and Plasma Free and Glucuronidated Cannabinoid Pharmacokinetics following Controlled Smoked Cannabis Administration For an occasional user, THC in blood generally becomes undetectable within about six to twelve hours. THC-COOH persists longer, possibly a day or two, but nothing like the weeks-long detection windows seen with urine testing.
A key point: occasional users have been defined in the research literature as people who smoke no more than about once a week. If you use cannabis a few times a week, your detection window is already longer than these numbers suggest, because THC and its metabolites start accumulating before the previous dose has fully cleared.
Detection Windows for Frequent Users
Here is where things get complicated. People who use cannabis daily or near-daily build up stores of THC in their body fat. Because THC is highly fat-soluble, it seeps into adipose tissue and releases back into the bloodstream slowly over time. THC-COOH, the inactive metabolite, can remain measurable in blood for days or even weeks after the last use in heavy consumers. Research has used THC-COOH thresholds to distinguish user types: occasional users tend to stay at or below about 3 micrograms per liter in whole blood, while heavy regular users (roughly ten or more times a month) often show levels at or above 40 micrograms per liter.4PubMed. Fitness to drive and cannabis: validation of two blood THCCOOH thresholds to distinguish occasional users from heavy smokers
Even THC itself, which most people think of as a short-lived marker, can linger in frequent users. One study found that after 12 hours of confirmed abstinence, more than half of 30 chronic cannabis users still had blood THC concentrations above 5 nanograms per milliliter, which is the legal per se limit in several U.S. states.5PubMed Central. Indeterminacy of cannabis impairment and ∆(9)-tetrahydrocannabinol (∆(9)-THC) levels in blood and breath They were not impaired at that point, but their blood would have flagged them under a strict per se threshold. This is one of the central frustrations with blood-based cannabis testing: in regular users, a “positive” blood test does not necessarily mean recent use and certainly does not confirm impairment.
Why Body Fat Matters
THC accumulates in fat tissue and can be released back into the bloodstream under conditions that promote fat breakdown. Animal research demonstrated that food deprivation and stress-related hormone exposure both enhanced the release of stored THC from fat cells, raising blood THC levels without any new cannabis intake.6PubMed Central. Reintoxication: the release of fat-stored delta(9)-tetrahydrocannabinol (THC) into blood is enhanced by food deprivation or ACTH exposure In humans, the picture is less dramatic. A small study of lean cannabis users who exercised or fasted found limited effects on blood THC, but the researchers noted that their participants had low body fat to begin with, and suggested that obese cannabis users would theoretically be more sensitive to this redistribution effect.7PubMed Central. Can Physical Exercise or Food Deprivation Cause Release of Fat-Stored Cannabinoids?
The practical takeaway is that body composition can stretch or compress your personal detection window. Someone who uses cannabis regularly and carries more body fat will tend to clear THC from their blood more slowly than a lean occasional user, even if they consumed the same amount.
Smoked Cannabis Versus Edibles
How you consume cannabis changes what your blood looks like to a lab. When you smoke or vape, THC floods into your bloodstream through the lungs, producing a sharp spike in plasma THC within minutes. Edibles take a different route: THC is absorbed through the gut and passes through the liver before reaching general circulation. This “first-pass” metabolism converts more THC into 11-OH-THC, the active metabolite.
A naturalistic study comparing inhaled flower with edibles found that plasma THC was significantly higher after smoking, but plasma levels of THC-COOH and 11-OH-THC were similar between the two groups. Interestingly, subjective intoxication and memory impairment were also comparable, even though the raw THC numbers in blood looked quite different.8PubMed Central. A naturalistic study of orally administered vs. inhaled legal market cannabis: cannabinoids exposure, intoxication, and impairment One other finding stood out from that study: for edible users, the amount of THC consumed correlated strongly with plasma THC levels, whereas for flower users, the correlation between how much they said they smoked and what showed up in their blood was weak. Smoking technique, inhalation depth, and other variables introduce a lot of noise.
This has practical implications if you are thinking about testing timelines. After edibles, THC blood levels rise more slowly and may stay elevated slightly longer than after smoking the same amount of THC, since absorption from the gut is slower and more drawn out.
Oral Fluid Testing and How It Compares
Roadside testing for cannabis typically uses oral fluid (saliva) rather than blood, because collecting a swab is faster and less invasive than drawing blood. Oral fluid can detect THC for a meaningful window: after a single controlled smoking session, all specimens tested positive for THC for up to 13.5 hours regardless of whether the person was a frequent or occasional smoker.9PubMed Central. Oral fluid cannabinoid concentrations following controlled smoked cannabis in chronic frequent and occasional smokers At commonly used cutoff levels of 1 or 2 micrograms per liter, detection windows extended beyond 30 hours for frequent smokers. For occasional smokers, the THC-COOH detection window in oral fluid was shorter, topping out at about 24 hours.
The correlation between oral fluid THC and blood THC is decent for detecting the presence of THC at all, with a sensitivity of about 71% and a specificity near 98%. But when oral fluid testing is used to predict whether someone is above a specific blood THC limit (like 5 nanograms per milliliter), accuracy drops and false positives increase substantially.10PubMed. Correlation between oral fluid and blood THC concentration: A systematic review and discussion of policy implications In other words, oral fluid is a reasonable screening tool for whether someone has used cannabis recently, but it is a poor proxy for actual blood concentration.
Blood THC Does Not Reliably Predict Impairment
One of the most persistent misconceptions about cannabis blood testing is that a higher THC level means a more impaired person. The relationship is far messier than that. A study of apprehended drivers found that those judged impaired had higher median blood THC than unimpaired drivers (2.5 versus 1.9 nanograms per milliliter), and that concentrations above 3 nanograms per milliliter were associated with increased risk of being judged impaired.11PubMed. Relationship between THC concentration in blood and impairment in apprehended drivers But those are group averages. The ranges overlapped enormously. Some impaired drivers had very low THC, and some unimpaired drivers had very high THC.
Controlled lab research tells a similar story. When researchers tracked performance on various tasks alongside serum THC, they found that the proportion of impaired observations did increase with higher THC: at serum concentrations between 5 and 10 nanograms per milliliter, about 75 to 90 percent of observations showed meaningful impairment, and at concentrations above 30, impairment was universal. But the direct linear correlation between THC concentration and the magnitude of impairment was weak.12PubMed. Cognition and motor control as a function of Delta9-THC concentration in serum and oral fluid: limits of impairment The researchers concluded that serum THC between 2 and 5 nanograms per milliliter represented the range where an impairment threshold could reasonably be drawn.
A driving simulation study underscored the problem with per se limits. Thirty minutes after vaporizing cannabis, all participants had blood and oral fluid THC above legal limits, yet 46 percent failed to meet the study’s criteria for actual driving impairment. Three and a half hours later, 57 percent showed impairment despite having median blood THC of just 1.0 nanogram per milliliter, which was below those same per se limits.13PubMed. The failings of per se limits to detect cannabis-induced driving impairment: Results from a simulated driving study THC blood levels and actual impairment can move in opposite directions for a given person at a given time.
Can Passive Exposure Cause a Positive Blood Test?
If you have been in a room where others were smoking cannabis, you are unlikely to test positive on a blood draw. An early study of passive cannabis smoke exposure found a complete absence of cannabinoids in blood samples taken from passively exposed subjects up to three hours after exposure.14PubMed. Passive inhalation of cannabis smoke While passive exposure can occasionally produce trace-positive results in urine under extreme conditions (a small, unventilated room with heavy smoke for extended periods), blood tests are far less susceptible to this because THC levels from secondhand smoke do not reach meaningful concentrations in the bloodstream.
Delta-8 THC and Cross-Reactivity
The recent explosion of delta-8 THC products, which are sold legally in many jurisdictions as hemp derivatives, has introduced a testing complication. Standard immunoassay screens for cannabis metabolites cannot reliably distinguish delta-8-THC-COOH from delta-9-THC-COOH. In laboratory testing, the common immunoassay used for delta-9-THC-COOH showed positive results for delta-8-THC-COOH at concentrations of 30 nanograms per milliliter or higher.15PubMed. Evaluation of a Delta-9-Tetrahydrocannabinol Carboxylic Acid (Δ9-THC-COOH) Immunoassay and a Gas Chromatography-Mass Spectrometry (GC-MS) Method for the Detection of Delta-8-Tetrahydrocannabinol Carboxylic Acid (Δ8-THC-COOH) The more advanced confirmatory method using gas chromatography-mass spectrometry was able to separate and independently identify the two compounds by their retention times. Still, this means initial screening tests can flag delta-8 users as positive for conventional cannabis, and only confirmatory testing can sort out which THC isomer is responsible.16PubMed Central. Delta-8-Tetrahydrocannabinol Exposure and Confirmation in Four Pediatric Patients
There is a laboratory-side wrinkle as well. Certain chemical derivatization methods used in gas chromatography can actually convert delta-9-THC into delta-8-THC during sample preparation, depending on the reagents used. When specific perfluoroacid reagents were employed, about 95 percent of a delta-9-THC sample isomerized into delta-8-THC, which could lead to misidentification. Switching to chloroform-based reagents eliminated the problem.17PubMed. Isomerization of delta-9-THC to delta-8-THC when tested as trifluoroacetyl-, pentafluoropropionyl-, or heptafluorobutyryl- derivatives This is an issue for labs, not for you directly, but it is a reminder that even confirmatory testing is only as good as the analytical methods used.
How Sample Handling Affects Your Results
Blood samples are biological specimens, and cannabinoid concentrations in them can change over time depending on storage conditions. THC in whole blood is stable for about 12 weeks when kept refrigerated at 4°C and about 12 weeks when frozen at minus 20°C. THC-COOH behaves differently: in whole blood at room temperature, it actually increases over time because the glucuronide form (THC-COOH-glucuronide) breaks down and releases free THC-COOH. That same metabolite is stable for about 4 weeks refrigerated and up to 26 weeks frozen.18PubMed Central. In Vitro Stability of Free and Glucuronidated Cannabinoids in Blood and Plasma Following Controlled Smoked Cannabis The research recommends that blood samples should be stored frozen (at minus 20°C) for no more than three months, and plasma samples for no more than six months, to ensure accurate quantitative results.
A separate study compared glass versus plastic collection tubes and found no meaningful difference in cannabinoid concentrations at frozen storage temperatures during the first month, and storage at refrigerator temperature (4°C) was acceptable for up to one week.19Toxicologie Analytique et Clinique. Sampling and storage conditions for cannabinoid analysis: Plastic vs. glass If you are ever in a situation where a blood test result seems off or is being contested, the chain of custody and storage conditions of the sample are legitimate points to question.
Postmortem Blood Testing and Why It Differs
This section matters less for most readers but is relevant in forensic and legal contexts. After death, cannabinoid concentrations in blood change. THC tends to redistribute from organs and fat tissue into the blood, and the direction of redistribution differs between central blood (drawn from near the heart) and peripheral blood (drawn from a limb vein). A meta-analysis found that postmortem blood generally shows significantly higher THC concentrations than antemortem blood, and that the ratio of THC to THC-COOH flips: while living blood usually shows THC-COOH concentrations equal to or higher than THC, many postmortem cases show the reverse.20PubMed. Postmortem redistribution of cannabinoids: Statistical analysis of a novel dataset and meta-analysis The redistribution patterns further showed that THC drifts toward peripheral blood while THC-COOH migrates toward central blood after death.
Earlier work measuring central-to-peripheral blood ratios found medians of about 1.5 for THC, 1.7 for 11-OH-THC, and 1.8 for THC-COOH, suggesting modest but consistent postmortem redistribution to central blood for all three cannabinoids.21PubMed Central. Postmortem redistribution of Δ9-tetrahydrocannabinol (THC), 11-hydroxy-THC (11-OH-THC), and 11-nor-9-carboxy-THC (THCCOOH) The bottom line for forensic interpretation is that postmortem blood THC levels cannot be straightforwardly compared to the per se limits used for living drivers. Careful interpretation using both central and peripheral samples is necessary.
What Labs Can Actually Detect at the Lowest Levels
The sensitivity of a blood test depends on the analytical method and the lab’s equipment. Modern liquid chromatography-tandem mass spectrometry methods can detect THC and 11-OH-THC at concentrations as low as 0.5 micrograms per liter and can quantify them reliably starting at 1.0 microgram per liter. For THC-COOH, the detection limit is somewhat higher at 2.0 micrograms per liter, with reliable quantification from 4.0 micrograms per liter.22Oxford Academic (Journal of Analytical Toxicology). Quantification of ∆9-tetrahydrocannabinol, 11-OH-THC, THC-COOH, hexahydrocannabinol, and cannabidiol in human plasma and blood by liquid chromatography-tandem mass spectrometry These are the current technical floors. Results reported below these limits should be treated with caution, and a “not detected” result does not necessarily mean zero THC in the blood; it means the amount, if present, was below what the instrument can confidently measure.
Workplace drug testing and roadside screening frequently use immunoassay methods first, which are faster and cheaper but less precise. These initial screens are designed to flag samples that need a closer look. A positive immunoassay gets sent for confirmatory testing using the more sensitive mass spectrometry methods. Understanding this two-step process helps explain why an initial positive does not always hold up: the screening test can cross-react with structurally similar compounds, and the confirmatory test is the one that provides a definitive answer.